<!doctype html>
<!--[if lt IE 7]><html class="no-js lt-ie9 lt-ie8 lt-ie7" lang="en"> <![endif]-->
<!--[if (IE 7)&!(IEMobile)]><html class="no-js lt-ie9 lt-ie8" lang="en"><![endif]-->
<!--[if (IE 8)&!(IEMobile)]><html class="no-js lt-ie9" lang="en"><![endif]-->
<!--[if gt IE 8]><!--> <html class="no-js" lang="en"><!--<![endif]-->
<head>
<meta charset="utf-8">
<title>Warfarin Therapy Management &#8211; Golnar k. Mahani</title>
<meta name="description" content="In this post the research work of B. Yet et al. titled, “Decision support system for Warfarin therapy management using Bayesian networks” has been reviewed.

">
<meta name="keywords" content="Warfarin therapy, Bayesian Network, DSS">


<!-- Twitter Cards -->
<meta name="twitter:title" content="Warfarin Therapy Management">
<meta name="twitter:description" content="In this post the research work of B. Yet et al. titled, “Decision support system for Warfarin therapy management using Bayesian networks” has been reviewed.

">



<meta name="twitter:card" content="summary">
<meta name="twitter:image" content="https://golnarMahani.github.io/images/site-logo.png">

<!-- Open Graph -->
<meta property="og:locale" content="en_US">
<meta property="og:type" content="article">
<meta property="og:title" content="Warfarin Therapy Management">
<meta property="og:description" content="In this post the research work of B. Yet et al. titled, “Decision support system for Warfarin therapy management using Bayesian networks” has been reviewed.

">
<meta property="og:url" content="https://golnarMahani.github.io/blog/warfarin-therapy-management/">
<meta property="og:site_name" content="Golnar k. Mahani">





<link rel="canonical" href="https://golnarMahani.github.io/blog/warfarin-therapy-management/">
<!-- <link href="https://golnarMahani.github.io/feed.xml" type="application/atom+xml" rel="alternate" title="Golnar k. Mahani Feed"> -->

<!-- https://t.co/dKP3o1e -->
<meta name="HandheldFriendly" content="True">
<meta name="MobileOptimized" content="320">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<!-- For all browsers -->
<link rel="stylesheet" href="https://golnarMahani.github.io/assets/css/main.css">
<!-- Webfonts -->
<script src="https://use.edgefonts.net/source-sans-pro:n2,i2,n3,i3,n4,i4,n6,i6,n7,i7,n9,i9;source-code-pro:n4,n7;volkhov.js"></script>

<meta http-equiv="cleartype" content="on">

<!-- HTML5 Shiv and Media Query Support -->
<!--[if lt IE 9]>
  <script src="https://golnarMahani.github.io/assets/js/vendor/html5shiv.min.js"></script>
  <script src="https://golnarMahani.github.io/assets/js/vendor/respond.min.js"></script>
<![endif]-->

<!-- Modernizr -->
<script src="https://golnarMahani.github.io/assets/js/vendor/modernizr-2.7.1.custom.min.js"></script>


<!-- MathJax -->
<script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>


<!-- Icons -->
<!-- 16x16 -->
<link rel="shortcut icon" href="https://golnarMahani.github.io/favicon.ico">
<!-- 32x32 -->
<link rel="shortcut icon" href="https://golnarMahani.github.io/favicon.png">
<!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
<link rel="apple-touch-icon-precomposed" href="https://golnarMahani.github.io/images/apple-touch-icon-precomposed.png">
<!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
<link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://golnarMahani.github.io/images/apple-touch-icon-72x72-precomposed.png">
<!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
<link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://golnarMahani.github.io/images/apple-touch-icon-114x114-precomposed.png">
<!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
<link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://golnarMahani.github.io/images/apple-touch-icon-144x144-precomposed.png">

</head>

<body id="post">

<div class="navigation-wrapper">
	<nav role="navigation" id="site-nav" class="animated drop">
	    <ul>
      
		    
		    <li><a href="https://golnarMahani.github.io/about/" >About</a></li>
		  
		    
		    <li><a href="https://golnarMahani.github.io/cv/" >My CV</a></li>
		  
		    
		    <li><a href="https://golnarMahani.github.io/blog/" >Blog</a></li>
		  
	    </ul>
	</nav>
</div><!-- /.navigation-wrapper -->

<!--[if lt IE 9]><div class="upgrade"><strong><a href="http://whatbrowser.org/">Your browser is quite old!</strong> Why not upgrade to a different browser to better enjoy this site?</a></div><![endif]-->



<div class="js-menu-screen menu-screen"></div>


<div id="main" role="main">
  <article class="hentry">
    
    <div class="entry-wrapper">
      <header class="entry-header">
        <ul class="entry-tags">
          <li><a href="https://golnarMahani.github.io/tags/#Warfarin therapy" title="Pages tagged Warfarin therapy">Warfarin therapy</a></li><li><a href="https://golnarMahani.github.io/tags/#Bayesian Network" title="Pages tagged Bayesian Network">Bayesian Network</a></li><li><a href="https://golnarMahani.github.io/tags/#DSS" title="Pages tagged DSS">DSS</a></li>
        </ul>
        
          <h1 class="entry-title">Warfarin Therapy Management</h1>
        
      </header>
      <footer class="entry-meta">
        
        
          <img src="https://golnarMahani.github.io/images/golnar-mahani-photo.jpg" class="bio-photo" alt="Golnar Mahani bio photo"></a>
        
        <span class="author vcard">By <span class="fn">Golnar Mahani</span></span>
        <span class="entry-date date published"><time datetime="2017-08-07T00:00:00+04:30"><i class="fa fa-calendar-o"></i> August 07, 2017</time></span>
        
        
        
        </footer>
      <div class="entry-content">
        <p>In this post the research work of B. Yet et al. titled, “Decision support system for Warfarin therapy management using Bayesian networks” has been reviewed.</p>

<p>Warfarin is an anticoagulant which is used for embolism and thrombosis prevention. The influence of this anticoagulant is examined by a normalized ratio of blood coagulation time of patient to a reference sample, known as International Normalized Ratio (INR). Since the response of patients to warfarin is different, the process of warfarin therapy is very challenging. Such variations in responses are caused by factors known as variation factors, including drug effects and comorbidities. Accordingly, assisting physicians with managing warfarin therapy through a decision support system is essential.<br />
In this paper, four major questions are covered in developing the warfarin therapy DSS:</p>

<ol>
  <li>How much dose should be adjusted for a specific patient?</li>
  <li>When should the patient take the next INR test?</li>
  <li>What are the cerebral bleeding and stroke risks for the patient?</li>
  <li>What are the variation factors that affect the response to the therapy?</li>
</ol>

<p>The following figure shows previous proposed DSS for Warfarin therapy. In the proportional-derivative and Bayes forecasting models the variation factors are not taken into account. Regression models do not provide dose adjustments for long-term therapies. Moreover, regression models and rule-based models require all the specified inputs to provide the user with an output. One of the other limitations of rule-based models is that the models could not provide a support for finding the cause of an unexpected INR increase.</p>

<figure>
	<img src="/images/Prev-DSS.png" alt="image" />
	<figcaption>Previous DSS for Warfarin Therapy.</figcaption>
</figure>

<p>Taking into account the limitations and drawbacks of the previous models, B. Yet et al. proposed a Bayesian network model for Warfarin therapy management.</p>

<h3 id="model-construction">Model Construction</h3>
<p>The patients were selected from those who received Warfarin therapy for more than 14 days (maintenance phase), because of the large number of patients and frequent patient status monitoring in this phase. <br />
The variation factors and the relation parameters between these factors and INR are elicited from experts. Since the conditional probability table (CPT) of INR in the proposed Bayesian model grows exponentially, parent divorcing technique and <a href="https://pdfs.semanticscholar.org/2ed3/d3e4bad4f9480338e50934d36120894b119e.pdf" target="_blank">Noisy Max model</a> were used to reduce the number of probabilities needed to be elicited. The remaining CPTs are learned from data. For these CPTs the data were preprocessed and after that the expectation maximization algorithm was used.<br />
For the probability elicitation by experts, two methods were used. In the first method, one expert was asked to express the conditional probabilities using numerical or verbal anchors. In the second method, the expert was asked to imagine 1000 Warfarin therapies to express the probability of a specified outcome of the specific parameter among those therapies. To reduce the errors of these methods, the authors suggested providing the expert the sensitivity analysis plots of INR, Dose change and follow-up intervals to the elicited variables.</p>

<p>The evaluation results show that the model has acceptable performance in dose recommendations, follow-up interval decisions and enhancement of variation factor investigation. However, the model could be more reliable if the authors have used more than one expert in the process of probability elicitation. Moreover, the models for bleeding and stroke risks should have been developed based on different patients not just the data of patients with atrial fibrillation. Also, in order to have a more generalized model, the initiation phase of Warfarin therapy should have been considered, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1288404/" target="_blank">since this phase is a critical dosing period with large amount of uncertainty and risks for adverse events.</a></p>
<h3 id="references">References</h3>

<hr />
<blockquote>
  <p><a href="https://doi.org/10.1016/j.dss.2012.10.007" target="_blank">B. Yet, K. Bastani, H. Raharjo, S. Lifvergren, W. Marsh, B. Bergman</a>, “Decision support system for Warfarin therapy management using Bayesian networks,” Decis. Support Syst., vol. 55, no. 2, pp. 488–498, May 2013.</p>

  <p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1288404/" target="_blank">C. R. Lee</a>, “Warfarin Initiation and the Potential Role of Genomic-Guided Dosing,” Clin. Med. Res., Vol. 3, no. 4, pp. 205-206, Nov. 2005.</p>

</blockquote>


      </div><!-- /.entry-content -->
    </div><!-- /.entry-wrapper -->
    <nav class="pagination" role="navigation">
      
        <a href="https://golnarMahani.github.io/blog/facial-expression-recognition/" class="btn" title="Facial Expression Recognition">Previous</a>
      
      
        <a href="https://golnarMahani.github.io/blog/RL-FS/" class="btn" title="Feature Selection Using RL">Next</a>
      
    </nav><!-- /.pagination -->
  </article>
</div><!-- /#main -->

<div class="footer-wrapper">
  <footer role="contentinfo" class="entry-wrapper">
    

<span>&copy; 2018 Golnar Mahani. Powered by <a href="http://jekyllrb.com" rel="nofollow">Jekyll</a>.</span>
<div class="social-icons">
	
	
	
	<a href="https://linkedin.com/in/golnar-k-mahani-a0020287" title="Golnar Mahani on LinkedIn" target="_blank"><i class="fa fa-linkedin-square fa-2x"></i></a>
	
	
	
	<a href="https://github.com/golnarMahani" title="Golnar Mahani on Github" target="_blank"><i class="fa fa-github-square fa-2x"></i></a>
	
  
	
  <!-- <a href="https://golnarMahani.github.io/feed.xml" title="Atom/RSS feed"><i class="fa fa-rss-square fa-2x"></i></a> -->
</div><!-- /.social-icons -->

  </footer>
</div><!-- /.footer-wrapper -->

<script type="text/javascript">
  var BASE_URL = 'https://golnarMahani.github.io';
</script>

<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.9.1/jquery.min.js"></script>
<script>window.jQuery || document.write('<script src="https://golnarMahani.github.io/assets/js/vendor/jquery-1.9.1.min.js"><\/script>')</script>
<script src="https://golnarMahani.github.io/assets/js/scripts.min.js"></script>




</body>
</html>
